Home / 2021 / July / 09

Daily Archives: July 9, 2021

XR Casino Aims to Disrupt Online Gambling and Sports Betting Industries through Augmented Reality (AR), Mixed Reality (MR) and Virtual Reality (VR) Technologies

XR Casino – Mixed Reality

Players can set up a casino in any room.

Global Extended Reality Market size expected to grow from 33 billion USD in 2021 to over 125 billion USD in 2026, at CAGR of 30%

US online sports betting market size expected to grow at 50% CAGR to reach 15 billion by 2025

Online gambling market size expected to grow at 11.5% CAGR to reach 127 billion USD by 2027

SAN JUAN, Puerto Rico, July 09, 2021 (GLOBE NEWSWIRE) — via InvestorWire — XR Casino, Inc (“XR Casino” or “The Company”), the first-ever cross-technology, multiplayer, blockchain technology-based online gambling platform for Extended Reality (XR) technologies such as Augmented Reality (AR), Mixed Reality (MR) and Virtual Reality (VR), today announces its MVP release date.

XR Casino – Virtual Reality

Use your favorite VR headset.

The Company is developing the first-ever extended reality platform that will allow users of different devices to play XR casino games with each other. The initial games include blackjack, roulette and slots and will be featured in its MVP version launching on August 21, 2021. Sports betting, baccarat, bingo, craps, poker and keno are in the development pipeline.

The list of supported devices includes Microsoft’s Hololens 1 and 2, Magic Leap’s Magic Leap 1, HTC Vive, Oculus Quest 2, Samsung’s Gear VR and AR-enabled smartphones as well as devices such as the Apple iPhone, iPad and over 39 Android smartphones and devices.

Game features include:

  • Multiplayer Games
  • Private Game Rooms
  • Public Game Rooms
  • Text and Voice Chats

“XR technologies are changing the way we interact with each other and eliminating the need for expensive equipment,” said XR Casino CEO Dan Martinez. “Tech giants such as Apple, Google, Facebook and Microsoft have invested heavily into AR, VR and MR to speed up mass adoption through both hardware and software solutions. XR Casino has first mover’s advantage in providing XR SaaS solutions to online, traditional casinos and sports betting companies. Our solutions create value for the gambling industry and offer competitive differentiation to attract new Generation X, Y and Z players worldwide.”

XR Casino – Mobile Augmented Reality

AR is already enabled in many smartphones including Apple iPhones.

About XR Casino, Inc.

XR Casino, Inc. is the first-ever cross-technology, multiplayer, blockchain technology-based online gambling platform for Extended Reality (XR) technologies such as Augmented Reality (AR), Mixed Reality (MR) and Virtual Reality (VR). For more information visit www.xr.casino.

Forward-Looking Statements

Certain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as may be disclosed in the Company’s filings. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release, and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release. Such forward-looking statements are risks that are detailed in the Company’s website and filings.

Contact:
[email protected]
[email protected]

Wire Service
InvestorWire
Los Angeles, California
www.InvestorWire.com
212.418.1217
[email protected]

Photos available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/ed5cfbf3-755a-4c5f-a832-9d14cafd7e7f
https://www.globenewswire.com/NewsRoom/AttachmentNg/cfda210a-f73a-4a23-909d-d1a5967ecda4
https://www.globenewswire.com/NewsRoom/AttachmentNg/a3c72329-0755-4e6e-a3ef-fa58045a6e2e

QuantuMDx launches Q-POC™ – rapid PCR point of care diagnostic system

QuantuMDx launches Q-POC™ – rapid PCR point of care diagnostic system

  • Roll out at ECCMID 2021 with Q-POC™ SARS-CoV-2 assay
  • 96.9% sensitivity, 98.3% specificity
  • Sample to result – approximately 30 minutes
  • CE-IVD marked – available to order now

NEWCASTLE UPON TYNE, UK, 09 July 2021. QuantuMDx Group Limited (‘QuantuMDx’ or the ‘Company’), a UK-based developer of transformational point-of-care diagnostics, today announces the launch of Q-POC™ – a rapid, PCR point of care diagnostic system.

Launching at ECCMID 2021, QuantuMDx’s Q-POC™ system and its first test, a SARS-CoV-2 detection assay, are now CE-IVD marked under the In Vitro Diagnostics Directive (98/79/EC), enabling use within Europe.

The Q-POC™ SARS-CoV-2 assay has been evaluated at St George’s, University of London, to assess clinical performance against tests in current use. The Development & Assessment of Rapid Technology (DART) Study shows 96.9% sensitivity (at CTs <35), 98.3% specificity and 0% cross reactivity with common commensal or potentially interfering organisms.

Q-POC™ is a portable PCR system which compresses an entire molecular diagnostic laboratory into a simple to use, accessible and affordable single device offering rapid, molecular diagnostic testing at the point of care, with results in approximately 30 minutes. Q-POC™ has been designed for front-line healthcare professionals and can be used within a wide range of settings, including emergency rooms, ICU, birthing centres, clinics, and pharmacies.

The Q-POC™ SARS-CoV-2 assay is contained within a sealed, single use test cassette designed for safety, ease of use and to eliminate contamination risk. On-board reagents are also lyophilised for room temperature storage, convenient shipping and a longer shelf life.

QuantuMDx’s Q-POC™ SARS-CoV-2 Assay has been designed with the most up-to-data sequence information to ensure 100% coverage of all known SARS-CoV-2 sequences.

Jonathan O’Halloran, Chief Executive, QuantuMDx, said: “Q-POC™ represents a new class of molecular diagnostic device: it’s fast, battery operated, can multiplex and is so simple to operate that anyone can be trained to use it. It’s a true point of care diagnostic system.

“Our Q-POC™ system is future-proof, and packs a great deal of complexity and power behind its modern lines and simple operation. Our SARS-CoV-2 test is just the first in a portfolio designed to meet real clinical needs. Over the next few years, we’ll be driving menu expansion, comprising large syndromic panels and antimicrobial resistance mutation panels, ensuring we remain at the forefront of molecular, point of care diagnostics globally.”

Sanjeev Krishna, Professor of Molecular Parasitology and Medicine at St George’s, University of London, said: “We are simply delighted to see the successful outcome of years of efforts to compress a diagnostics laboratory into a simple, portable and flexible device. The Q-POC™ platform was invented to address urgent diagnostic needs, particularly for pinch points for COVID-19 management in the NHS, and the community. In addition, how great is it to see the Northern Powerhouse delivering for us, with great potential to expand quickly and tackle other looming challenges like winter flu and antimicrobial resistance.”

Jonathan O’Halloran added: “Working with our British manufacturing partner, Cogent Technology and Singapore-based, Univac, we have scaled manufacturing to ensure security of supply for our customers and we are excited to be open for business.”

QuantuMDx was awarded £16m UK government funding in March 2020 to develop the company’s portable diagnostic testing system, Q-POC™, and disposable cassettes to allow for rapid, point-of-care testing for the SARS-CoV-2 virus in high and low-resource settings. The funding also included £3.2m towards production of QuantuMDx’ lab-based coronavirus test which is now commercially available.

For more information about QuantuMDx and Q-POC™, its rapid PCR point of care system, go to: www.quantumdx.com.

Notes to editor:

1)   Q-POC™ brochure and video

2)   Professor Sanjeev Krishna is a shareholder and advisor to QuantuMDx

About QuantuMDx:

QuantuMDx Group is an ambitious company with a global vision of empowering the world to control and eradicate disease by making transformative, quality point-of-care diagnostic technologies universally accessible. QuantuMDx has operations and strategic partnerships in the United States, Asia, Australasia, Europe and Africa – keeping it at the forefront of molecular diagnostics. For more information go to: www.quantumdx.com

For media enquiries:

Debra Daglish, Marketing Communications Manager, QuantuMDx Group, 0870 803 1234

Chris Gardner, Matthew Neal and Lindsey Neville, Consilium Strategic Communications, 0203 709 5700 / [email protected]

For investor enquiries:

Financial Adviser: WG Partners LLP; David Wilson (020 3705 9315), Nigel Barnes (020 3705 9318), Claes Spång (020 3705 9317)

XR Casino ตั้งเป้าที่จะปฏิวัติอุตสาหกรรมการพนันออนไลน์และการพนันกีฬาผ่านเทคโนโลยี Augmented Reality (AR), Mixed Reality (MR) และ Virtual Reality (VR)

คาดว่าขนาดของตลาด Global Extended Reality จะเติบโตจาก 33 พันล้านเหรียญสหรัฐฯ ในปี 2021 เป็นมากกว่า 125 พันล้านเหรียญสหรัฐฯ ในปี 2026 ที่ CAGR 30%

คาดว่าขนาดของตลาดการพนันกีฬาออนไลน์ของสหรัฐฯ จะเติบโตที่ 50% CAGR ถึง 15 พันล้านภายในปี 2025

คาดว่าขนาดของตลาดการพนันออนไลน์จะเติบโตที่ 11.5% CAGR ถึง 127 พันล้านเหรียญสหรัฐฯ ภายในปี 2027

ซานฮวน, เปอร์โตริโก, July 09, 2021 (GLOBE NEWSWIRE) —  ผ่าน InvestorWire — XR Casino, Inc (ต่อไปนี้จะเรียกว่า “XR Casino” หรือ “บริษัท”) แพลตฟอร์มการพนันออนไลน์ที่ใช้เทคโนโลยีแบบผสมผสาน มัลติเพลย์เยอร์ บล็อคเชนเป็นครั้งแรกสำหรับเทคโนโลยี Extended Reality (XR) เช่น Augmented Reality (AR), Mixed Reality (MR) และ Virtual Reality (VR) วันนี้ประกาศวันเปิดตัว MVP

บริษัทกำลังพัฒนาแพลตฟอร์มเสมือนจริงแบบขยายเป็นครั้งแรกที่ช่วยให้ผู้ใช้อุปกรณ์ที่แตกต่างกัน สามารถเล่นเกมคาสิโน XR ร่วมกันได้ โดยจะมีเกมเริ่มแรก ได้แก่ แบล็กแจ็ก รูเล็ต และสล็อต และจะนำเสนอในเวอร์ชัน MVP ที่จะเปิดตัวในวันที่ 21 สิงหาคม 2021 การพนันกีฬา บาคาร่า บิงโก แครบส์ โป๊กเกอร์ และคีโนกำลังอยู่ในระหว่างการพัฒนา

อุปกรณ์ที่รองรับ ได้แก่ Hololens 1 และ 2 ของ Microsoft, Magic Leap 1 ของ Magic Leap, HTC Vive, Oculus Quest 2, Gear VR ของ Samsung และสมาร์ทโฟนและอุปกรณ์ที่รองรับ AR เช่น Apple iPhone, iPad และสมาร์ทโฟนและอุปกรณ์ Android กว่า 39 รายการ

คุณสมบัติของเกมประกอบด้วย:

  • เกมแบบผู้เล่นหลายคน
  • ห้องเล่นเกมส่วนตัว
  • ห้องเล่นเกมสาธารณะ
  • การแชทด้วยข้อความและเสียง

“เทคโนโลยี XR กำลังทำให้วิธีที่เราโต้ตอบกันเปลี่ยนไป และทำให้ไม่ต้องใช้อุปกรณ์ราคาแพง” Dan Martinez CEO ของ XR Casino กล่าว “ยักษ์ใหญ่ด้านเทคโนโลยี เช่น Apple, Google, Facebook และ Microsoft ได้ลงทุนอย่างหนักใน AR, VR และ MR เพื่อเร่งการปรับใช้จำนวนมากผ่านโซลูชันฮาร์ดแวร์และซอฟต์แวร์ XR Casino มีความได้เปรียบในการเป็นผู้เริ่มต้นจัดหาโซลูชัน XR SaaS ให้กับคาสิโนออนไลน์ คาสิโนแบบดั้งเดิม และบริษัทพนันกีฬา โซลูชันของเราสร้างมูลค่าให้กับอุตสาหกรรมการพนัน และนำเสนอความแตกต่างเชิงการแข่งขันเพื่อดึงดูดผู้เล่น Generation X, Y และ Z ใหม่ทั่วโลก”

เกี่ยวกับ XR Casino, Inc.

XR Casino, Inc. เป็นแพลตฟอร์มการพนันออนไลน์ที่ใช้เทคโนโลยีแบบผสมผสาน มัลติเพลย์เยอร์ บล็อคเชนเป็นครั้งแรกสำหรับเทคโนโลยี Extended Reality (XR) เช่น Augmented Reality (AR), Mixed Reality (MR) และ Virtual Reality (VR) ดูข้อมูลเพิ่มเติมได้ที่ www.xr.casino

ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคต

ข้อความบางส่วนในข่าวประชาสัมพันธ์ฉบับนี้อาจเป็น “ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคต” ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตจะคาดการณ์ในปัจจุบันของเหตุการณ์ในอนาคตตามสมมติฐานบางประการ และรวมถึงข้อความใดๆ ที่ไม่เกี่ยวข้องโดยตรงกับข้อเท็จจริงในอดีตหรือปัจจุบัน ผลลัพธ์ที่แท้จริงอาจแตกต่างอย่างมากจากที่ระบุโดยข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตดังกล่าว อันเป็นผลมาจากปัจจัยสำคัญต่างๆ ที่อาจเปิดเผยในเอกสารที่ยื่นต่อบริษัท นอกจากปัจจัยเหล่านี้ ผลการดำเนินงานในอนาคตที่แท้จริง ผลประกอบการ และผลลัพธ์อาจแตกต่างกันอย่างมากเนื่องจากปัจจัยทั่วไปมากขึ้น ซึ่งรวมถึง (แต่ไม่จำกัดเพียง) สภาพอุตสาหกรรมและตลาดทั่วไปและอัตราการเติบโต ภาวะเศรษฐกิจ และการเปลี่ยนแปลงนโยบายของรัฐบาลและสาธารณะ ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตที่รวมอยู่ในข่าวประชาสัมพันธ์ฉบับนี้แสดงถึงมุมมองของบริษัท ณ วันที่ของข่าวประชาสัมพันธ์ฉบับนี้ และมุมมองเหล่านี้อาจเปลี่ยนแปลงได้ อย่างไรก็ตาม ในขณะที่บริษัทอาจเลือกที่จะปรับปรุงข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตเหล่านี้ในบางจุดในอนาคต บริษัทขอปฏิเสธภาระผูกพันใดๆ ที่จะต้องดำเนินการดังกล่าว ไม่ควรยึดถือข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตเหล่านี้ว่าเป็นการแสดงความเห็นของบริษัท ณ วันที่ใดๆ ต่อจากวันที่ในข่าวประชาสัมพันธ์ ข้อความเชิงคาดการณ์เหตุการณ์ในอนาคตดังกล่าวนั้นว่าด้วยความเสี่ยงซึ่งมีรายละเอียดอยู่ในเว็บไซต์และการยื่นเอกสารของบริษัท

ติดต่อ:
[email protected]
[email protected]

Wire Service
InvestorWire
ลอสแองเจลิส, แคลิฟอร์เนีย
www.InvestorWire.com
212.418.1217
[email protected]

รับชมภาพถ่ายได้ที่
https://www.globenewswire.com/NewsRoom/AttachmentNg/ed5cfbf3-755a-4c5f-a832-9d14cafd7e7f
https://www.globenewswire.com/NewsRoom/AttachmentNg/cfda210a-f73a-4a23-909d-d1a5967ecda4
https://www.globenewswire.com/NewsRoom/AttachmentNg/a3c72329-0755-4e6e-a3ef-fa58045a6e2e

Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares

REGULATED INFORMATION
INSIDE INFORMATION

Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters’ Full Exercise of Option to Purchase Additional Shares

Mont-Saint-Guibert, Belgium – July 8, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the closing on July 7, 2021 of its initial public offering in the United States (the “Offering”) of 2,835,000 ordinary shares at a price to the public of US$30 per share for total gross proceeds of US$85.1 million before deducting underwriting discounts and commissions and estimated offering expenses. In addition, Nyxoah announced today that the underwriters of the Offering have exercised their option to purchase additional shares in full. The option to purchase additional shares granted to the underwriters was for the purchase of up to an additional 425,250 new ordinary shares, at the public offering price of US$30 per share, before underwriting discounts and commissions. This exercise will bring the total gross proceeds of the Offering to US$97.8 million before deducting underwriting discounts and commissions and estimated offering expenses.   The closing of the exercise of the option to purchase additional shares is expected to occur on July 9, 2021, subject to the satisfaction of customary closing conditions.

Piper Sandler, Stifel and Cantor acted as joint book-running managers for the offering. Degroof Petercam acted as a co-manager.

A registration statement relating to the ordinary shares was filed with the Securities and Exchange Commission (“SEC”) and declared effective on June 30, 2021. This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction.

The offering of ordinary shares was made only by means of a prospectus. A copy of the final prospectus can be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by e-mail at [email protected], or by phone at (800) 747-3924; Stifel, Nicolaus & Company, Incorporated at Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 364-2720, or by email at [email protected]; or Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 4th Floor, New York, New York 10022; email: [email protected].

Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements,” including, without limitation, statements regarding the closing of the shares to be sold pursuant to the exercise of the option to purchase additional ordinary shares. Forward-looking statements are based on Nyxoah’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and could cause actual results to differ. Forward-looking statements contained in this announcement are made as of this date, and Nyxoah undertakes no duty to update such information except as required under applicable law.

IMPORTANT INFORMATION
No public offering will be made and no one has taken any action that would, or is intended to, permit a public offering in any country or jurisdiction, other than the United States, where any such action is required, including in Belgium. Belgian investors, other than qualified investors within the meaning of the Belgian Act of 11 July 2018 on the public offering of securities and the admission of securities to be traded on a regulated market, will not be eligible to participate in the offering (whether in Belgium or elsewhere). The transaction to which this press release relates will only be available to, and will be engaged in only with, in member states of the European Economic Area, persons falling within the meaning of Article 2(e) of Regulation (EU) 2017/1129 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market (the “Prospectus Regulation”), and in the United Kingdom, investment professionals falling within article 19 (5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), persons falling within article 49 (2), (a) to (d) of the Order and other persons to whom it may lawfully be communicated. A listing prospectus will be prepared by Nyxoah in accordance with Article 3 of the Prospectus Regulation for the purpose of having the new ordinary shares, issued pursuant to the Offering and the exercise by the underwriters of their option to purchase additional ordinary shares, admitted to trading on Euronext Brussels.

Contacts:
Nyxoah
Fabian Suarez, Chief Financial Officer
[email protected]
+32 (0)10 22 24 55

Gilmartin Group
Vivian Cervantes
[email protected]

Attachment

UniSZA contributes electric wheelchair for OKU student

The plight of a disabled student who finds it difficult to undergo industrial training due to limited movements has caught the attention of University Sultan Zainal Abidin (UniSZA).

Normelisa Mohd Yadi, 23, a final-year student of the Bachelor of Arabic Studies (Hons), received an electric wheelchair to ease her movement without the help of others to undergo her training.

UniSZA deputy vice-chancellor (Students and Alumni Affairs) said the RM2,800 electric wheelchair was donated by the university’s Wakaf and Infaq office, and Normelisa was the first student to receive it.

“We understand Normelisa’s difficulties due to her limited movements to undergo industrial training at a company in Kota Bharu, Kelantan since July 3.’

“This is a new situation for her because, during her stay at UniSZA, she and other students with disabilities were assisted by fellow students to attend lectures and live on campus,” he told reporters here.

UniSZA was among the OKU friendly universities in the country, providing various facilities to the group, among others, wheelchairs, refrigerators to keep medicines, electric scooters, eye control technology for the visually impaired to use computers, student assistants and a buggy as well.

Meanwhile, Normelisa, who is paralysed on both legs since childhood, said the contribution of the electric wheelchair further boosted her motivation to do her best during her industrial training at the company.

“Thank you very much to UniSZA for always looking after the welfare of OKU students and being sensitive to our needs,” she said, adding about 40 OKU students are studying at the university.

Source: BERNAMA News Agency

Perak govt to ensure aid continues, vaccination programme a success – Saarani

The Perak government will continue to mobilise all of its resources to revive the economy and assist the people, besides also ensuring its vaccination programme is a success.

Menteri Besar Datuk Saarani Mohamad, who is Perak UMNO liaison chief, said UMNO must show political determination in making decisions, especially in the face of ongoing difficult situations faced by the people.

“Facing increasingly challenging political realities and threats to the practice of parliamentary democracy demand that the COVID-19 pandemic is dealt with accordingly,” he said in a statement today.

Meanwhile, Perak UMNO also congratulated Datuk Seri Ismail Sabri Yaakob dan Datuk Seri Hishammuddin Tun Hussein over their appointments as Deputy Prime Minister and Senior Minister respectively.

“Armed with vast experience, it is hoped that these two UMNO leaders will make the best of their positions to help resolve the COVID-19 crisis and help those who have been impacted to rebuild their lives,” he said.

Source: BERNAMA News Agency

Hospital: Blood drives must be kept going

— Donor blood has a short shelf life hence donating blood regularly can make a difference, said Hospital Raja Perempuan Zainab II (HRPZ II) director, Datuk Dr Selasawati Ghazali.

“We’ve carried out various initiatives to replenish the blood stock. It’s not at a critical level. We have sufficient supply to last five to seven days.

“However, we have to ensure there is enough available because it is always needed, not just by HRPZ II, but district and private hospitals, too,” she said during a blood drive organised by Kelab Kebajikan Asnaf Kelantan (KKAK) in Tanjung Mas today.

Kelantan state executive councillor, Datuk Mumtaz Md Nawi, Kelantan Contingent Police Headquarters (IPK) commercial crime investigation department chief, Supt Ahmad Azizul Mohamed and KKAK chairman, Meor Shamshir Meor Zulkifli Auni, were also present.

Dr Selasawati said donor blood has a shelf life of one and a half months and that 60 – 80 bags are needed on a typical day for transfusions.

“It is mostly needed following childbirth, for accident cases and during emergency surgery.

Source: BERNAMA News Agency